Takanori Yamaguchi Selected Research

Takanori Yamaguchi Research Topics

Disease

5	Atrial Fibrillation 01/2020 - 01/2016
3	Tachycardia (Tachyarrhythmias) 11/2018 - 01/2010
3	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2014 - 07/2013
2	Hemorrhage 01/2022 - 01/2022
2	Leukemia 02/2021 - 04/2016
2	Hypertension (High Blood Pressure) 12/2019 - 01/2014
2	Hodgkin Disease (Hodgkin's Disease) 05/2018 - 03/2017
2	Neuralgia (Stump Neuralgia) 08/2007 - 05/2005
2	Hyperalgesia 08/2007 - 05/2005
1	Rhabdomyosarcoma 10/2023
1	Bacteremia 10/2023
1	Fever (Fevers) 10/2023
1	Pulmonary Embolism 10/2023
1	Body Weight (Weight, Body) 10/2023
1	Neoplasms (Cancer) 10/2023
1	Mucositis 10/2023
1	Myocardial Infarction 01/2022
1	Breast Neoplasms (Breast Cancer) 02/2021
1	Inflammation (Inflammations) 02/2021
1	Churg-Strauss Syndrome (Allergic Angiitis) 01/2021
1	Vasculitis (Vasculitides) 01/2021
1	Heart Failure 01/2020
1	Endophthalmitis (Ophthalmia) 01/2020
1	Proteinuria 12/2019
1	Urinary Tract Infections (Urinary Tract Infection) 12/2019
1	Cicatrix (Scar) 01/2019
1	Cardiac Arrhythmias (Arrythmia) 01/2019
1	Blister (Bulla) 03/2017
1	Acute Retinal Necrosis Syndrome 03/2017
1	Herpes Zoster 03/2017
1	Enterocolitis 01/2017
1	Diabetic Nephropathies (Diabetic Nephropathy) 01/2017
1	Thrombocytopenia (Thrombopenia) 01/2017
1	Erythema Infectiosum (Fifth Disease) 01/2017
1	Anemia 01/2017
1	Infections 01/2017
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 04/2016
1	Thrombophilia 04/2016
1	Unconsciousness (Loss of Consciousness) 04/2016
1	Rupture 04/2016
1	Disseminated Intravascular Coagulation 04/2016
1	Thrombosis (Thrombus) 04/2016
1	Intracranial Hemorrhages (Intracranial Hemorrhage) 04/2016
1	Hemiplegia (Spastic Hemiplegia) 04/2016

Drug/Important Bio-Agent (IBA)

2	Interleukin-6 (Interleukin 6)IBA 10/2023 - 07/2013
2	CytokinesIBA 10/2023 - 07/2013
2	Proteins (Proteins, Gene)FDA Link 02/2021 - 05/2005
2	Anti-Arrhythmia AgentsIBA 11/2018 - 06/2018
2	Phosphorus (Red Phosphorus)IBA 01/2014 - 11/2013
2	ZincIBA 01/2014 - 11/2013
1	Cisplatin (Platino)FDA LinkGeneric 10/2023
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 10/2023
1	Tissue Plasminogen Activator (Alteplase)FDA Link 01/2022
1	Streptokinase FDA Link 01/2022
1	Serum AlbuminIBA 01/2022
1	Hemoglobins (Hemoglobin)IBA 01/2022
1	AlbuminsIBA 01/2022
1	CollagenIBA 02/2021
1	Fibronectins (Fibronectin)IBA 02/2021
1	IntegrinsIBA 02/2021
1	Extracellular Matrix ProteinsIBA 02/2021
1	ThrombomodulinIBA 02/2021
1	LectinsIBA 02/2021
1	Immunoglobulin G (IgG)IBA 01/2021
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2021
1	Immunosuppressive Agents (Immunosuppressants)IBA 01/2021
1	mepolizumabIBA 01/2021
1	Succimer (Dimercaptosuccinic Acid)FDA Link 12/2019
1	GadoliniumIBA 01/2019
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 05/2018
1	Dacarbazine (DIC)FDA LinkGeneric 05/2018
1	Brentuximab VedotinIBA 05/2018
1	Bleomycin (Blenoxane)FDA LinkGeneric 05/2018
1	Vincristine (Oncovin)FDA LinkGeneric 05/2018
1	Vinblastine (Vinblastine Sulfate)FDA Link 05/2018
1	Prednisone (Sone)FDA LinkGeneric 05/2018
1	Doxorubicin (Adriamycin)FDA LinkGeneric 05/2018
1	Valacyclovir (Valtrex)FDA LinkGeneric 03/2017
1	Acyclovir (Aciclovir)FDA LinkGeneric 03/2017
1	DNA (Deoxyribonucleic Acid)IBA 01/2017
1	AnticoagulantsIBA 04/2016
1	Asparaginase (Elspar)FDA Link 04/2016
1	Cytarabine (Cytosar-U)FDA LinkGeneric 04/2016
1	Heparin (Liquaemin)FDA LinkGeneric 04/2016
1	Dexamethasone (Maxidex)FDA LinkGeneric 04/2016
1	Immunoglobulins (Immunoglobulin)IBA 01/2016

Therapy/Procedure

6	Drug Therapy (Chemotherapy) 10/2023 - 01/2016
6	Catheter Ablation 01/2020 - 01/2010
4	Therapeutics 02/2021 - 04/2016
2	Ligation 08/2007 - 05/2005
1	Central Venous Catheters 10/2023
1	Percutaneous Coronary Intervention 01/2022
1	Immunotherapy 02/2021
1	Molecular Targeted Therapy 02/2021
1	Patient Readmission 01/2020
1	Intravitreal Injections 01/2020
1	Anesthesia 01/2018
1	Intravenous Anesthesia 01/2018
1	Renal Dialysis (Hemodialysis) 01/2017
1	Erythrocyte Transfusion 01/2017